Michael Trauner

Research interests

Publications

• Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

  ˜The œLancet. Gastroenterology & hepatology · 2023 · https://doi.org/10.1016/s2468-1253(23)00141-3

• EASL Clinical Practice Guidelines on sclerosing cholangitis

  Journal of Hepatology · 2022 · https://doi.org/10.1016/j.jhep.2022.05.011

• Gut-liver axis: Pathophysiological concepts and clinical implications

  Cell Metabolism · 2022 · https://doi.org/10.1016/j.cmet.2022.09.017

• Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

  Gut · 2021 · https://doi.org/10.1136/gutjnl-2021-324243

• Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.02.027

• Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.02.027

• Detection of Various Microplastics in Human Stool

  Annals of Internal Medicine · 2019 · https://doi.org/10.7326/m19-0618

• Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease

  Annual Review of Pathology Mechanisms of Disease · 2018 · https://doi.org/10.1146/annurev-pathol-020117-043617

• Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

  Gastroenterology · 2017 · https://doi.org/10.1053/j.gastro.2017.02.038

• Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

  Nature Reviews Gastroenterology & Hepatology · 2016 · https://doi.org/10.1038/nrgastro.2016.51

• Bile acids and nonalcoholic fatty liver disease

  Hepatology · 2016 · https://doi.org/10.1002/hep.28709

• A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1509840

• New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond

  Journal of Hepatology · 2015 · https://doi.org/10.1016/j.jhep.2015.02.023

• Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

  Annals of the Rheumatic Diseases · 2012 · https://doi.org/10.1136/annrheumdis-2012-202469

• ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1

  Nature Medicine · 2011 · https://doi.org/10.1038/nm.2439

• The interaction of hepatic lipid and glucose metabolism in liver diseases

  Journal of Hepatology · 2011 · https://doi.org/10.1016/j.jhep.2011.08.025

• Fatty liver and lipotoxicity

  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2009 · https://doi.org/10.1016/j.bbalip.2009.10.007

• Bile Salt Transporters: Molecular Characterization, Function, and Regulation

  Physiological Reviews · 2003 · https://doi.org/10.1152/physrev.00027.2002

• Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors.

  Journal of Clinical Investigation · 1998 · https://doi.org/10.1172/jci1680

• The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis

  Gastroenterology · 1997 · https://doi.org/10.1016/s0016-5085(97)70103-3

Current projects

No projects listed.